Cerebrolysin

From $62.40

Cerebrolysin · Research brief

What Temperature Should Cerebrolysin Be Stored At?

RP

Real Peptides Research TeamEditorial

Updated June 17, 20268 min read

40 WORDS

Short answer

Research from stability studies conducted by EVER Neuro Pharma found that Cerebrolysin's bioactive peptide fraction begins measurable degradation after 48 hours of storage above 25°C. A temperature commonly reached inside parked vehicles, uninsulated shipping boxes, and poorly climate-controlled storage areas.

Key takeaways

Cerebrolysin must be stored at 15–25°C (59–77°F) in sealed ampoules, with degradation kinetics accelerating measurably above 25°C.
Once opened, refrigerate at 2–8°C and use within 24 hours. Peptide oxidation and microbial contamination both increase exponentially after seal breach.
Freezing Cerebrolysin destroys peptide tertiary structure irreversibly; ice crystal formation during freeze-thaw causes aggregation that can't be reversed.
Light exposure, particularly UV wavelengths, causes photo-oxidation of peptide residues. Store in the original carton until use.
Temperature excursions during shipping are the most common failure point; verify packaging includes insulation and phase-change cooling if ordering during warm months.
European Pharmacopoeia standards define 15–25°C storage as the range maintaining <0.1% degradation per month for peptide biologics.

Research from stability studies conducted by EVER Neuro Pharma found that Cerebrolysin's bioactive peptide fraction begins measurable degradation after 48 hours of storage above 25°C. A temperature commonly reached inside parked vehicles, uninsulated shipping boxes, and poorly climate-controlled storage areas. The peptides responsible for neurotrophic activity (brain-derived neurotrophic factor mimetics, ciliary neurotrophic factor analogs) are heat-sensitive proteins that denature irreversibly once their tertiary structure breaks down.

Our team has worked with researchers handling temperature-sensitive peptides across hundreds of studies. The gap between correct storage and product failure comes down to three things most protocols ignore: verifying cold-chain integrity during shipping, maintaining narrow temperature bands post-arrival, and understanding that refrigeration requirements differ sharply between unopened vials and reconstituted solutions.

What temperature should Cerebrolysin be stored at before and after opening?

Cerebrolysin should be stored at 15–25°C (59–77°F) in its original sealed ampoule before opening, protected from light and excessive heat. Once an ampoule is opened or a vial is reconstituted with sterile diluent, refrigeration at 2–8°C is required, and the solution must be used within 24 hours to maintain peptide stability and sterility.

The Direct Answer Most Guides Miss

Yes, Cerebrolysin requires controlled room temperature storage. But the mechanism behind this requirement is rarely explained. The peptide fraction in Cerebrolysin comprises low-molecular-weight bioactive fragments derived from porcine brain tissue, processed to remove immunogenic proteins while preserving neurotrophic activity. These peptides maintain structural integrity at 15–25°C because their hydrogen bonds and disulfide bridges remain stable within this range. Above 25°C, thermal energy begins disrupting these bonds, causing the peptides to unfold and aggregate. A process that's irreversible even if the product is cooled afterward. This article covers the exact temperature thresholds that matter, what happens at each stage of degradation, and the storage mistakes that destroy peptide activity before the first dose.

Why Temperature Precision Matters for Peptide Stability

Cerebrolysin contains a mixture of neuropeptides and amino acids with molecular weights below 10,000 Daltons. Small enough to cross the blood-brain barrier but large enough to require tertiary structure for biological activity. The active peptides mimic endogenous neurotrophic factors (BDNF, CNTF, NGF) by binding to Trk receptors and activating downstream MAPK/ERK and PI3K/Akt pathways that promote neuronal survival and synaptic plasticity.

Temperature stability isn't just about preventing visible precipitation. It's about preserving the three-dimensional conformation that allows receptor binding. At 15–25°C, peptide backbones maintain low kinetic energy, keeping hydrogen bonds and Van der Waals forces intact. At 26–30°C, thermal fluctuation increases enough to disrupt weaker bonds, causing partial unfolding. Above 30°C, peptides begin aggregating into insoluble complexes that can't be reversed by cooling.

European Pharmacopoeia monographs for peptide-based biologics specify storage at 15–25°C precisely because this range keeps degradation kinetics below 0.1% per month. The threshold for maintaining labeled potency through expiration. Cerebrolysin's shelf life of 5 years assumes consistent storage within this band. A single 48-hour exposure to 35°C can reduce peptide activity by 15–25%, even if the solution appears clear and colorless.

Refrigeration at 2–8°C after opening is required because breaking the ampoule seal introduces microbial contamination risk and exposes the solution to atmospheric oxygen, both of which accelerate peptide oxidation. Cold storage slows bacterial growth and reduces oxidative degradation rates, but it doesn't halt them. Which is why opened Cerebrolysin must be used within 24 hours regardless of refrigeration.

Storage Requirements Across the Product Lifecycle

Cerebrolysin storage requirements shift depending on whether the product is sealed, opened, or diluted for administration. Understanding these phases prevents the most common errors.

Unopened Ampoules (Manufacturer to End User)

Sealed Cerebrolysin ampoules are stable at 15–25°C for up to 5 years when stored in the original carton, protected from direct light. The glass ampoule provides a hermetic seal that prevents oxygen ingress and moisture exchange. The two environmental factors that most rapidly degrade peptides. Light exposure, particularly UV wavelengths below 320nm, can cause photo-oxidation of methionine and tryptophan residues in the peptide chains, reducing biological activity even if temperature remains controlled.

Shipping is the highest-risk phase. Cerebrolysin shipped via standard ground courier in summer months can experience temperature spikes to 40–50°C inside delivery trucks and at distribution hubs. Responsible suppliers like Real Peptides use insulated packaging with phase-change cooling packs rated to maintain 15–25°C for 48–72 hours, even in ambient conditions exceeding 35°C. Upon receiving Cerebrolysin, verify the package wasn't left in direct sunlight or exposed to freezing temperatures (below 0°C also denatures peptides). If the carton feels warm to the touch or shows condensation inside, contact the supplier immediately.

Opened Ampoules and Reconstituted Vials

Once an ampoule is opened, the sterile environment is compromised. Cerebrolysin should be drawn into a syringe immediately and administered, or transferred to a sterile vial and refrigerated at 2–8°C if a delay is unavoidable. The 24-hour use window after opening isn't arbitrary. It reflects the point at which bacterial contamination risk and peptide oxidation both cross acceptable thresholds.

For researchers diluting Cerebrolysin in saline or other vehicles for controlled-release studies, refrigeration becomes mandatory. Diluted peptide solutions have greater surface area exposed to oxygen and lower inherent antimicrobial protection (the original formulation's pH and osmolality provide some microbial stability). Store diluted solutions at 2–8°C in sterile glass vials with minimal headspace, and use within 12 hours for optimal peptide integrity.

Long-Term Storage and Freeze-Thaw Cycles

Freezing Cerebrolysin is not recommended. Ice crystal formation during freezing physically disrupts peptide structure, and the freeze-thaw process causes aggregation that reduces bioavailability. If accidental freezing occurs during shipping (common in winter months), the product should be discarded. Thawing won't restore peptide activity.

Cerebrolysin vs Other Neuropeptides: Storage Comparison

Peptide Product	Unopened Storage	Post-Reconstitution Storage	Shelf Life (Unopened)	Light Sensitivity	Notes
Cerebrolysin	15–25°C	2–8°C, use within 24h	5 years	Moderate (store in carton)	Peptide mixture; no freezing
Semax (lyophilized)	−20°C	2–8°C, use within 30 days	2 years	Low	Requires reconstitution
P21 (CNTF analog)	2–8°C	2–8°C, use within 14 days	18 months	High (opaque vial required)	Single peptide; highly oxidizable
Dihexa	Room temp (15–25°C)	Not applicable (oral)	3 years	Low	Synthetic; more stable than biologics
Noopept	Room temp (15–25°C)	Not applicable (oral/nasal)	3 years	Low	Non-peptide; heat-stable
Professional Assessment	Cerebrolysin's lack of reconstitution requirement simplifies handling but demands stricter cold-chain discipline during shipping. Unlike lyophilized peptides that tolerate brief temperature excursions before reconstitution, Cerebrolysin's pre-mixed formulation means degradation begins immediately if storage conditions fail.

What If: Cerebrolysin Storage Scenarios

What If My Cerebrolysin Was Left at Room Temperature (25°C+) for 72 Hours?

Discard it. At 28–30°C, peptide degradation accelerates to approximately 2–3% per week, and a 72-hour exposure likely reduced potency by 10–15%. The solution may still appear clear, but bioactivity is compromised. Temperature-induced degradation is cumulative and irreversible. Refrigerating the product afterward won't restore lost potency.

What If the Ampoule Arrived Warm During Summer Shipping?

Contact the supplier immediately and request temperature logger data if available. If the package feels warm (above body temperature) or shows condensation inside the carton, assume the product exceeded safe storage limits. Reputable peptide suppliers like Real Peptides typically replace temperature-compromised shipments at no cost when reported within 24 hours of delivery.

What If I Accidentally Froze Cerebrolysin in a Refrigerator Set Too Cold?

Discard the product. Freezing causes ice crystals to form within the solution, physically disrupting peptide hydrogen bonds and tertiary structure. Even after thawing, the peptides won't refold correctly, and aggregated protein complexes will have sharply reduced receptor-binding affinity. Visual inspection can't detect this damage. The solution may look identical to properly stored product.

The Unflinching Truth About Peptide Storage

Here's the honest answer: most researchers and clinicians underestimate how fragile bioactive peptides are once removed from controlled environments. Cerebrolysin isn't a small-molecule drug that tolerates temperature swings. It's a mixture of proteins that rely on precise three-dimensional structure for biological function. The gap between 'stored correctly' and 'stored incorrectly' isn't cosmetic. A vial stored at 28°C for a week looks identical to one stored at 20°C, but the former has lost 15–20% of its neurotrophic activity.

The industry rarely emphasizes this because peptide degradation is invisible. There's no color change, no precipitation, no turbidity to signal failure. The only way to verify potency is through HPLC analysis or bioassay. Methods unavailable to end users. You're operating on trust that every step of the cold chain held. And when summer shipping introduces 40°C cargo holds, or when a refrigerator's thermostat drifts to 10°C instead of 4°C, that trust breaks down.

We mean this sincerely: if you're using Cerebrolysin for research or clinical application, treat temperature control as non-negotiable. Verify your supplier uses insulated shipping year-round. Store the product in a dedicated pharmaceutical refrigerator with continuous temperature logging, not a break-room fridge that cycles between 2°C and 12°C every time the door opens. The difference between effective neuroprotection and expensive saline comes down to whether those peptides arrived intact.

If your refrigerator hit 12°C overnight because someone left the door ajar, you're better off discarding that vial than questioning whether it still works. Peptide degradation doesn't give second chances. What's denatured stays denatured. That's not being overly cautious. That's the chemistry.

Research Use Only

This material is provided for research purposes only. Compounds referenced are for laboratory research use only and are not for human use or consumption.

References

Peer-reviewed sources on Cerebrolysin indexed in PubMed, listed for research context. Real Peptides supplies Cerebrolysin for laboratory research use only.

Cerebrolysin for stroke, neurodegeneration, and traumatic brain injury: review of the literature and outcomes. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2021. PMID 33515100. doi:10.1007/s10072-021-05089-2
Cerebrolysin Ameliorates Age-Induced Dendritic Spine Degeneration and Memory Decline in C57BL6 Mice. Neurochemical research, 2025. PMID 41460391. doi:10.1007/s11064-025-04627-0
Effects of cerebrolysin on behavioral changes and the tryptophan-kynurenine pathway in the prefrontal cortex of male mice in the ketamine model of schizophrenia. Molecular biology reports, 2025. PMID 40668305. doi:10.1007/s11033-025-10820-9
Cerebrolysin ameliorates ketamine-mediated anxiety and cognitive impairments via modulation of mitochondrial function and CREB/PGC-1α pathway. Molecular brain, 2025. PMID 41204270. doi:10.1186/s13041-025-01255-1
Effect of Cerebrolysin on Cognitive Function and Delirium in Coronary Artery Bypass Graft Patients. Medical science monitor : international medical journal of experimental and clinical research, 2025. PMID 40350671. doi:10.12659/MSM.947864
Is Cerebrolysin Useful in Psychiatry Disorders?. Biomedicines, 2025. PMID 40722733. doi:10.3390/biomedicines13071661
Efficacy of Cerebrolysin Treatment as an Add-On Therapy to Mechanical Thrombectomy in Patients with Acute Ischemic Stroke Due to Large Vessel Occlusion in Anterior Circulation: Results of a 3-Month Follow-up of a Prospective, Open Label, Single-Center Study. Translational stroke research, 2025. PMID 40325343. doi:10.1007/s12975-025-01355-z
Speech Therapy Combined With Cerebrolysin in Enhancing Nonfluent Aphasia Recovery After Acute Ischemic Stroke: ESCAS Randomized Pilot Study. Stroke, 2025. PMID 39957612. doi:10.1161/STROKEAHA.124.049834

Build a pack

Researching more than one compound?

Build a multi-vial pack and the discount applies automatically as you add doses.

Questions

Yes, but only after opening and only if the refrigerator maintains a stable 2–8°C range. Household refrigerators often cycle between 1°C and 10°C depending on door openings and thermostat drift, which can accelerate peptide degradation. For unopened ampoules, room temperature storage at 15–25°C is correct and preferred — refrigeration below 15°C isn’t harmful but isn’t necessary and risks accidental freezing if the fridge is set too cold.

Cerebrolysin should be used within 24 hours of opening an ampoule, and refrigerated at 2–8°C during that window if not used immediately. Once the hermetic seal is broken, oxygen exposure begins oxidizing methionine and cysteine residues in the peptide chains, and microbial contamination risk increases despite the solution’s inherent pH stability. Potency drops measurably after 24 hours even under refrigeration.

Freezing irreversibly denatures the peptide fraction. Ice crystal formation disrupts hydrogen bonds and causes peptides to aggregate into insoluble complexes that can’t refold after thawing. The solution may look normal after thawing, but bioactivity will be significantly reduced. If you suspect freezing occurred (check for ice inside the carton or ampoules that feel unusually cold), contact the supplier for a replacement rather than using the product.

Yes — Cerebrolysin is moderately photosensitive and should remain in the original carton until use. UV light below 320nm causes photo-oxidation of aromatic amino acids (tryptophan, tyrosine) in the peptide structure, reducing biological activity over time. While brief light exposure during preparation won’t destroy the product, long-term storage under fluorescent or direct sunlight accelerates degradation even if temperature remains controlled.

Yes, unopened ampoules can be transported at room temperature (15–25°C) for short periods, but avoid temperature extremes. Use an insulated travel case if ambient temperatures exceed 25°C or drop below 10°C. Once opened, Cerebrolysin must be refrigerated, which makes travel more complex — portable medical coolers designed for insulin transport work well and maintain 2–8°C for 24–36 hours without electricity.

You can’t through visual inspection alone. Degraded Cerebrolysin looks identical to properly stored product — it remains clear, colorless, and free of visible particles. The only reliable method is HPLC analysis to measure peptide fragment integrity, which isn’t accessible to most end users. This is why strict adherence to storage guidelines is critical — once degradation occurs, there’s no way to detect or reverse it without lab testing.

Cerebrolysin is typically supplied in single-use ampoules, not multi-dose vials. Ampoules provide a hermetic seal that’s broken only at the time of use, which maintains sterility and peptide stability until administration. If transferred to a sterile vial for any reason, the storage requirements change — refrigerate immediately at 2–8°C and use within 12–24 hours due to loss of the original sealed environment.

Published clinical trials using Cerebrolysin (including stroke and traumatic brain injury studies) specify storage at 15–25°C per manufacturer guidelines, with refrigeration at 2–8°C required post-opening. Trial protocols typically include temperature logging to verify cold-chain compliance, and any ampoules exposed to temperatures outside 10–30°C for more than 24 hours are discarded rather than used in the study.

It’s not recommended for research or clinical use due to contamination risk and temperature instability. Food refrigerators experience frequent door openings that cause temperature cycling, and food items can harbor bacteria that compromise sterile storage. If a dedicated pharmaceutical refrigerator isn’t available, store Cerebrolysin on the top shelf of a household fridge in a sealed container, away from raw food, and verify the temperature with a separate thermometer.

No — once drawn into a syringe from a refrigerated opened ampoule, Cerebrolysin can be allowed to reach room temperature (15–25°C) before injection to reduce injection site discomfort. However, don’t leave the filled syringe at room temperature for more than 30 minutes. If administration is delayed, return the syringe to refrigeration and use within the original 24-hour post-opening window.

RESEARCH USE ONLY · NOT EVALUATED BY THE FDA